Rian Hollister: PlasmaFlow As An Option for Continued DVT Prevention
Rian Hollister, Territory Manager at Recon Supply, shared on LinkedIn:
”To all my fellow veterans, ask your VA providers/staff about PlasmaFlow as an option for continued DVT prevention from hospital/medical facility to home.
‘U.S. Centers for Medicare and Medicaid Services (CMS) declared deep vein thrombosis (DVT) a Never Event in 2008, yet it remains the leading cause of preventable death in hospitalized patients each year.’
‘The PlasmaFlow™ Portable Compression Device can reduce DVT risk by providing hospital-quality vascular compression therapy to patients wherever they recover.
DVT risk doesn’t end when a patient is discharged.
With more high-risk surgeries moving from inpatient to outpatient settings, effective compression therapy after discharge is critical.
CHEST guidelines recommend extending thromboprophylaxis in the outpatient period for up to 35 days from the day of surgery for patients undergoing major orthopedic surgery.’
- 60% of HA-VTEs occur after patients have been discharged.
- As many as 70% of HA-VTE cases in patients could be prevented.
“Healthcare-associated venous thromboembolism (HA-VTE) leads to approximately 100,000 premature deaths annually.”
Mean time to presentation for symptomatic DVT:
Total Knee Arthroplasty (TKA) patients = 19.5 days
Total Hip Arthroplasty (THA) patients = 22.5 days
‘The PlasmaFlow™ Portable Compression Device provides continuous DVT prevention for patients returning home to recover.
This portable compression device is comfortable and convenient, ensuring better protection for patients and peace of mind for providers.”’
Stay updated with Hemostasis Today.
-
Feb 15, 2026, 04:45In Memoriam: Dr. Lynn Malec
-
Feb 15, 2026, 03:59Benjamin YQ Tan: Why Patient-Reported Outcomes Matter in Young Stroke Survivors Returning to Work
-
Feb 14, 2026, 22:00Rodrigo Assar: 12 Influential Papers on Thrombosis and Hemostasis Innovative Modeling
-
Feb 14, 2026, 17:18Sonal Sonu: A Compatible Crossmatch Does Not Guarantee Transfusion Safety
-
Feb 14, 2026, 17:15Nasrin Haghani: Vitamin D and Omega-3 Fatty Acids May Support Mood Regulation
-
Feb 14, 2026, 17:14Joseph Raffaele: How Gut Aging Drives Cardiovascular Risk
-
Feb 14, 2026, 17:03Mohamed Sayed Abdelmoneim: Addressing a Persistent Challenge in Posterior Circulation Ischemic Stroke
-
Feb 14, 2026, 16:58Paul Bolaji: Strengthening Stroke Care in Africa Through Collaboration and Evidence
-
Feb 14, 2026, 16:56Can we Boost Emicizumab Without Increasing Thrombosis Risk? – RPTH Journal